Keros Therapeutics

Developer of small molecules to treat hematologic and musculoskeletal disorders

placeLexington, Massachusetts, United States calendar_todayFounded 2016 groups136 employees language kerostx.com

Registered entities

Innovation

31 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 5,535 times.

YearFilings
20182
20195
20207
202110
202214
202313
202419
202523
20266

Social engagement

Social engagement: 9.1K social following, 5 posts in the last 12 months — above the industry median.

Investor mix

11 investors on record; lead investors include Foresite Capital, Orbimed, Venrock, Pontifax.

Investor typeCountShare
Venture capital655%
Private equity19%
Other / undisclosed436%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

9 Feb 2026 · Research Informatics Specialist Data Solutions Lead (Contract) · Lexington

Based on job postings tracked across public sources.

Coming soon